Sign in
Explore the registryTrack Ritlecitinib's trials

Tranquillo LTE

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

RitlecitinibOngoingActive not recruitingPhase 3Open NCT06163326 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…